Recognition and Publications
Stone M, Shore-Lesserson L, Martinelli G, Maayani S. The anti-aggregatory effects of clopidogrel are due to enchancement of platelet deaggregation. Anesth Analg 2000;90:SCA12.
Shore-Lesserson L, Saleem R, Stone M, et al: Evaluation of the Ultegra®, Point-of-Care Platelet Function Instrument during Cardiac Surgery. Anesthesiology 2000;93:A313.
Kataria TC, Stone ME, Harrington D, Shore-Lesserson L. Reopro Thromboelastography During Cardiopulmonary Bypass. Anesth Analg 2002;93:SCA90.
Kataria TC, Stone M, Shore-Lesserson L. Long Cardiopulmonary Bypass Time Predicts Postoperative Bleeding Despite Strict Utility of Transfusion Algorithms. Anesthesiology 2002;96:A129.
Shore-Lesserson L, Sanders JB, Stone M, and Harrington D: "Use of the High Dose Thrombin Time to Measure Heparin Anticoagulation in Heparinized Patients Having Cardiac Surgery". Anesth Analg 2004;98:S33.
Shore-Lesserson L, Fischer G, Sanders J, Mitchell-Bligen M, and Stone M. Clopidogrel Induces a Platelet Aggregation Defect That Is Partially Mitigated By Ex-Vivo Addition of Aprotinin. Anesthesiology 2004;101:A268.
Sanders J, Shore-Lesserson L, Apinis A. Influence of Aprotinin on a Celite-Activated Heparin Management Test (Rapidpoint®). Anesthesia and Analgesia 2004.
Weiss M, Stone ME, Mitchell-Bligen, Winfree W, Shore-Lesserson L. Point-of-Care Devices Detect the Clopidogrel-Induced Inhibition of Platelet Aggregation As Well As Aggregometry. Anesthesia and Analgesia 2005;100:SCA55. Anesthesiology 2005; 103: A393.